Dx & Vx Co., Ltd. engages in the development of molecular diagnostic products. It operates through the following business divisions: Molecular diagnostics, Bio-reagents, Postmortem specimen, and International treatment. The Molecular diagnostic business division provides deoxyribonucleic acid (DNA) chips and polymerase chain reaction(PCR) kits. The Bio-reagents business division offers PCR, DNA amplification, and enzyme products. The Postmortem specimen business division operates a funeral hall. The company was founded on June 16, 2001 and is headquartered in Seoul, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company